J Korean Med Sci.  2013 Jan;28(1):145-151. 10.3346/jkms.2013.28.1.145.

Tinea Incognito in Korea and Its Risk Factors: Nine-Year Multicenter Survey

Affiliations
  • 1Department of Dermatology, Pusan National University School of Medicine, Busan, Korea. drkmp@hanmail.net
  • 2Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
  • 3Department of Dermatology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
  • 4Department of Dermatology, Kyungpook National University School of Medicine, Daegu, Korea.
  • 5Department of Dermatology, Kyung Hee University College of Medicine, Seoul, Korea.
  • 6Department of Dermatology, Keimyung University School of Medicine, Daegu, Korea.
  • 7Department of Dermatology, Korea University College of Medicine, Seoul, Korea.
  • 8Department of Dermatology, Kosin University College of Medicine, Busan, Korea.
  • 9Department of Dermatology, The Catholic University of Daegu College of Medicine, Daegu, Korea.
  • 10Department of Dermatology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
  • 11Department of Dermatology, Dong-A University College of Medicine, Busan, Korea.
  • 12Department of Dermatology, Maryknoll Medical Center, Busan, Korea.
  • 13Department of Dermatology, Seoul National University Bundang Hostpital, Seongnam, Korea.
  • 14Department of Dermatology, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
  • 15Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • 16Department of Dermatology, Ajou University School of Medicine, Suwon, Korea.
  • 17Department of Dermatology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • 18Department of Dermatology, Wonju Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • 19Department of Dermatology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • 20Department of Dermatology, Inha University College of Medicine, Incheon, Korea.
  • 21Department of Dermatology, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.
  • 22Department of Dermatology, Chonbuk National University Medical School, Jeonju, Korea.
  • 23Department of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea.
  • 24Department of Dermatology, Chungbuk National University School of Medicine, Cheongju, Korea.
  • 25Department of Dermatology, Hallym University College of Medicine, Anyang, Korea.
  • 26Department of Dermatology, Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
  • 27Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea.

Abstract

Tinea incognito (TI) is a dermatophytic infection which has lost its typical clinical appearance because of improper use of steroids or calcineurin inhibitors. The incidence of TI is increasing nowadays. We conducted retrospective review on 283 patients with TI from 25 dermatology training hospitals in Korea from 2002-2010 to investigate the demographical, clinical, and mycological characteristics of TI, and to determine the associated risk factors. More than half (59.3%) patients were previously treated by non-dermatologists or self-treated. The mean duration of TI was 15.0 +/- 25.3 months. The most common clinical manifestations were eczema-like lesion, psoriasis-like, and lupus erythematosus-like lesion. The trunk and face were frequently involved, and 91 patients (32.2%) also had coexisting fungal infections. Among 67 isolated strains, Trichophyton rubrum was the most frequently detected (73.1%). This is the largest study of TI reported to date and the first investigational report concerning TI in Korea. We suggest that doctors should consider TI when a patient has intractable eczema-like lesions accompanied by tinea pedis/unguium. Furthermore, there should be a policy change, which would make over-the-counter high-potency topical steroids less accessible in some countries, including Korea.

Keyword

Calcineurin Inhibitor; Dermatophytoses; Korea; Steroid; Tinea; Tinea Incognito

MeSH Terms

Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Demography
Eczema/pathology
Face/pathology
Female
Humans
Lupus Erythematosus, Cutaneous/pathology
Male
Middle Aged
Psoriasis/pathology
Republic of Korea
Retrospective Studies
Risk Factors
Tinea/*diagnosis/microbiology
Trichophyton/isolation & purification
Young Adult

Figure

  • Fig. 1 Various features of tinea incognito (A-G). Vitiligo-like (A; pre-treatment, B; after 4 weeks of application of topical pimecrolimus, C; 6 weeks after topical antifungal treatment), contact dermatitis-like (D), nonspecific eczema-like (E), seborrheic dermatitis-like (F), and lupus erythematosus-like (G) lesions.


Cited by  1 articles

Tinea Incognito with Folliculitis-Like Presentation: A Case Series
Min-Woo Kim, Hyun-Sun Park, Jeong Mo Bae, Hyun-Sun Yoon, Soyun Cho
Ann Dermatol. 2018;30(1):97-99.    doi: 10.5021/ad.2018.30.1.97.


Reference

1. Romano C, Maritati E, Gianni C. Tinea incognito in Italy: a 15-year survey. Mycoses. 2006. 49:383–387.
2. del Boz J, Crespo V, Rivas-Ruiz F, de Troya M. Tinea incognito in children: 54 cases. Mycoses. 2011. 54:254–258.
3. Ive FA, Marks R. Tinea incognito. Br Med J. 1968. 3:149–152.
4. Ansar A, Farshchian M, Nazeri H, Ghiasian SA. Clinico-epidemiological and mycological aspects of tinea incognito in Iran: a 16-year study. Med Mycol J. 2011. 52:25–32.
5. Arenas R, Moreno-Coutino G, Vera L, Welsh O. Tinea incognito. Clin Dermatol. 2010. 28:137–139.
6. Lange M, Jasiel-Walikowska E, Nowicki R, Bykowska B. Tinea incognito due to Trichophyton mentagrophytes. Mycoses. 2009. 53:455–457.
7. Rallis E, Koumantaki-Mathioudaki E. Pimecrolimus induced tinea incognito masquerading as intertriginous psoriasis. Mycoses. 2008. 51:71–73.
8. Garcia-Doval I, Cabo F, Monteagudo B, Alvarez J, Ginarte M, Rodriguez-Alvarez MX, Abalde MT, Fernandez ML, Allegue F, Perez-Perez L, Florez A, Cabanillas M, Peon G, Zulaica A, Del Pozo J, Gomez-Centeno P. Clinical diagnosis of toenail onychomycosis is possible in some patients: cross-sectional diagnostic study and development of a diagnostic rule. Br J Dermatol. 2010. 163:743–751.
9. Rajpar SF, Abdullah A. Management of onychomycosis and awareness of guidelines among dermatologists. Br J Dermatol. 2006. 155:1080–1082.
10. Choi YL, Kim JA, Rho NK, Lee DY, Lee JH, Yang JM, Lee ES, Kim WS. A case of tinea incognito induced by 1% pimecrolimus (Elidel) cream. Korean J Dermatol. 2006. 44:731–733.
11. Hsiao YP, Lin HS, Wu TW, Shih HC, Wei SJ, Wang YL, Lin KL, Chiou HL, Yang JH. A comparative study of KOH test, PAS staining and fungal culture in diagnosis of onychomycosis in Taiwan. J Dermatol Sci. 2007. 45:138–140.
12. Wollina U, Hansel G, Koch A, Abdel-Naser MB. Topical pimecrolimus for skin disease other than atopic dermatitis. Expert Opin Pharmacother. 2006. 7:1967–1975.
13. Crawford KM, Bostrom P, Russ B, Boyd J. Pimecrolimus-induced tinea incognito. Skinmed. 2004. 3:352–353.
14. Siddaiah N, Erickson Q, Miller G, Elston DM. Tacrolimus-induced tinea incognito. Cutis. 2004. 73:237–238.
15. Yang CW, Lee BG, Lee MH, Kim NI. A case of tinea incognito. Korean J Dermatol. 1989. 27:79–82.
16. Kang HY, Son HC, Lim YS, Cho YW, Han JY. A case of tinea incognito on the face due to Trichophyton mentagrophytes. Korean J Dermatol. 2000. 38:1124–1126.
17. Kim KJ, Jee MS, Choi JH, Sung KJ, Moon KC, Koh JK. A case of tinea incognito presented as folliculitis. Korean J Dermatol. 2001. 39:1328–1330.
18. Han TY, Rho YK, Seo SJ, Hong CK, Song KY. A case of tinea incognito presented like furunculosis. Korean J Med Mycol. 2008. 13:138–141.
19. Park SB, Lee YW, Park EJ, Kwon IH, Kim KH, Kim KJ. A case of tinea faciei caused by Trichophyton mentagrophytes with atypical presentation. Korean J Med Mycol. 2010. 15:170–174.
20. Hwang SM, Kim DM, Suh MK, Ha GY, Kim JR. Eczema-like tinea incognito occurring leg. Korean J Med Mycol. 2011. 16:51–55.
21. Lee JS, Cho YS, Song KH, Hwang SR, Park J, Yun SK, Kim HU. Tinea incognito with changes in clinical feature related to antifungal treatment. Korean J Med Mycol. 2011. 16:118–123.
22. Kim WJ, Song M, Kim HS, Kim SH, Ko HC, Kim BS, Kim MB. Various nail disorders misdiagnosed and treated as onychomycosis. Korean J Dermatol. 2011. 49:408–414.
23. Szepietowski JC, Matusiak L. Trichophyton rubrum autoinoculation from infected nails is not such a rare phenomenon. Mycoses. 2008. 51:345–346.
24. Nenoff P, Mugge C, Herrmann J, Keller U. Tinea faciei incognito due to Trichophyton rubrum as a result of autoinoculation from onychomycosis. Mycoses. 2007. 50:Suppl 2. 20–25.
25. Serarslan G. Pustular psoriasis-like tinea incognito due to Trichophyton rubrum. Mycoses. 2007. 50:523–524.
26. Schieke SM, Garg A. Fungal disease. Fitzpatrick's dermatology in general medicine. 2012. 8th ed. NewYork: McGraw-Hill;2277–2297.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr